Malignant Hyperthermia: Review of Diagnosis and Treatment during Cardiac Surgery with Cardiopulmonary Bypass.

Autor: Butala B; Department of Anesthesiology, Allegheny Health Network, Pittsburgh, PA. Electronic address: Brian.butala@gmail.com., Busada M; Department of Anesthesiology, Allegheny Health Network, Pittsburgh, PA., Cormican D; Department of Anesthesiology, Allegheny Health Network, Pittsburgh, PA; Department of Critical Care Medicine, Allegheny Health Network, Pittsburgh, PA.
Jazyk: angličtina
Zdroj: Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2018 Dec; Vol. 32 (6), pp. 2771-2779. Date of Electronic Publication: 2018 Mar 20.
DOI: 10.1053/j.jvca.2018.03.029
Abstrakt: Malignant hyperthermia is a potentially life-threatening hypermetabolic disorder, often induced by exposure to volatile anesthetics and succinylcholine. There are few reports of malignant hyperthermia during cardiopulmonary bypass. Here the authors review available literature including case reports of malignant hyperthermia and cardiopulmonary bypass and discuss the potential implications of malignant hyperthermia diagnosis and management as it applies to cardiac surgery.
(Copyright © 2018 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: